Coronary Stents Market

1
Coronary Stents Market Analysis, By Type (Dual
therapy stents, Drug eluting stents, Bare Metal
Stents, Bioresorbable Vascular Scaffold,
Bio-engineered) End Use (Hospital, Ambulatory
Surgical Centers, Cardiac Centers), Material
(Metal, Polymer, Copolymer) and Forecast by 2026
www.reportsanddata.com
2
Market Summary
According to the current analysis of Reports and
Data, the global Coronary Stents market was
valued at USD 8.30 Billion in 2018 and is
expected to reach USD 15.37 Billion by the year
2026 at a CAGR of 7.9. Stents are small
expandable tubes that are used to treat narrowed
or weakened arteries. A coronary stent is a small
mesh tube that holds open passages in the body
such as weak or narrow arteries. It is a small
tube shaped device placed in the coronary
arteries, which supply blood to the heart, to
keep the arteries open in the treatment of
coronary heart diseases. The coronary stents
are used in almost all the percutaneous coronary
intervention (PCI) procedures. Stents reduce
chest pains and have been proven to have improved
chances of survival and decrease adverse events
in the acute myocardial infraction. Coronary
Stents market is continuously growing. With the
rising advancements and launch of new products,
there is huge scope to the product. Browse
Complete Report _at_ https//www.reportsanddata.com/r
eport-detail/coronary-stents-market
www.reportsanddata.com
3

• Further key findings from the report suggest
• Minimal invasiveness has been attracting the
  attention of many in the recent times. Since
  Coronary Angioplasty is one of the types of
  minimal intrusive treatments, there has been a
  spur of growth in the demand for this procedure.
  Increasing cases of coronary artery diseases, has
  triggered research and development initiatives to
  develop several innovative solutions for the
  treatment purposes, which lays a foundation for
  future growth.
• Hospitals dominate the market with a market share
  of 63. This is due to the extensive facilities
  offered in hospitals.
• The coronary stents are of two types in terms of
  delivery. These include, balloon expandable
  stents and self-expandable stents.
• The existence of alternatives for coronary
  angioplasty has also become a restraining factor
  for the coronary stents market. These
  alternatives include procedures such as
  Atherectomy, Laser angioplasty, coronary artery
  bypass etc.
• Recent developments have encouraged the market to
  the very large extent. For instance, the recent
  launch of Dual Therapy Stents (DTS) is a one of
  its kind type of stent. The DTS is a combination
  of Drug Eluding Stents and Bio-engineered Stent.
  It has a coating on the inside as well as outside
  making the chances of blood clots, inflammations
  and tissue injuries less likely. The DTS is seen
  to grow at a rate of 8.8.

www.reportsanddata.com
4

• Among the types of stents, Drug Eluting Stents,
  being the most time tested type of stents,
  dominate the market. They are the considered to
  be the safest and the most time tested among all
  the other types of stents. They are expected to
  grow at a rate of 7.7.
• North America dominates the market with the
  highest market share. The changing dietary habits
  and cases of obesity have led to an increase in
  the cases of CAD i.e. Coronary Artery Disease.
  The market is expected to grow at a CAGR of 7.7.
• Europe follows North America closely and holds
  the highest market share amounting to 30.4. This
  can be attributed to the rising technological
  advancements in the region. The region is
  expected to register a CAGR of 7.6.
• Asia Pacific is seen to be the fastest growing
  region with a CAGR of 8.7. This can be
  attributed to the increasing geriatric population
  in the region and the rising cases of Coronary
  Artery Disease. Several governments in this
  region have taken initiatives to make medical
  facilities and surgical procedures affordable.
  Asia Pacific holds a market share of around
  26.6.
• The key players of the market include Boston
  Scientific Corporation, Medtronic Plc, Abbott
  Laboratories, B. Braun Melsungen AG, Vascular
  Concepts, Stentys SA, Biosensors International
  Group Ltd. and Orbus Neich.

www.reportsanddata.com
5

• For the purpose of this report, Reports and Data
  has segmented the Coronary Stents market on the
  basis of type, material, end use and region
• By Type (Revenue, USD Million 20162026)
• Dual Therapy Stents
• Drug Eluting Stents
• Bio-engineered Stents
• Bare Metal Stents
• Bioresorbable Vascular Scaffold (BVS)
• By End Use (Revenue, USD Million 20162026)
• Hospitals
• Ambulatory Surgical Centers
• Cardiac Centers
• By Material (Revenue, USD Million 20162026)
• Metal

www.reportsanddata.com
6

• Regional Outlook (Volume, Kilo Tons 2016-2027
  and Revenue, USD Million 2016-2027)
• North America
• U.S.
• Canada
• Europe
• Germany
• France
• UK
• Spain
• Italy
• Rest of the Europe
• Asia Pacific
• China
• India
• Japan
• Rest of Asia-Pacific
• Middle East Africa
• Latin America

www.reportsanddata.com
7
About Us
Reports and Data is a market research and
consulting company that provides syndicated
research reports, customized research reports,
and consulting services. Our solutions purely
focus on your purpose to locate, target and
analyze consumer behavior shifts across
demographics, across industries and help clients
make a smarter business decision. We offer
market intelligence studies ensuring relevant and
fact-based research across a multiple industries
including Healthcare, Technology, Chemicals,
Power, and Energy. We consistently update our
research offerings to ensure our clients are
aware about the latest trends existent in the
market. Reports and Data has a strong base of
experienced analysts from varied areas of
expertise.
Contact US
John Watson Head of Business Development Reports
And Data Web www.reportsanddata.com Direct
Line 1-212-710-1370 E-mail sales_at_reportsanddata
.com
www.reportsanddata.com